Skip to main content
. Author manuscript; available in PMC: 2018 Oct 1.
Published in final edited form as: J Pediatr. 2017 Jul 10;189:169–174.e2. doi: 10.1016/j.jpeds.2017.06.021

Table II.

Patient characteristics by Enterovirus testing group

Patient Characteristics CSF EV PCR Not Tested
N=15,509
n (%)
CSF EV PCR Tested
N=4,444
n (%)
p-value

Demographics

Age 29–60 days 6,909 (44.5) 1,994 (44.9) 0.86

Male gender 8,538 (55.1) 2,523 (56.8) 0.04

Presentation during peak enteroviral seasona 5,854 (37.7) 2,885 (64.9) < 0.001

Laboratory

Abnormal urinalysisb 2,774 (17.9) 530 (11.9) < 0.001

WBC ≥ 15,000 cells/mm3 2,723 (17.6) 673 (15.1) < 0.001

CSF cell count obtained 12,897 (83.2) 3,005 (67.6) < 0.001
 CSF pleocytosis presentc 2,924 (22.7) 1,163 (38.7)
 CSF pleocytosis absentc 9,973 (77.3) 1,842 (61.3)

Disposition

Intensive care unit admission 2,624 (16.9) 688 (15.5) 0.02

Bacterial infections

Invasive bacterial infectiond 465 (3.0) 92 (2.1) 0.001

Any SBIe 1,483 (9.6) 227 (5.1) < 0.001
 UTI 1,141 (7.4) 151 (3.4)
 Bacteremia 361 (2.3) 76 (1.7)
 Bacterial meningitis 152 (1.0) 30 (0.7)
No SBI 14,026 (90.4) 4,217 (94.9)
a

June to October

b

Positive nitrite, positive leukocyte esterase or > 5 WBCs/hpf

c

CSF WBC ≥ 20 cells/mm3 for infants 0 to 28 days of age and CSF WBC ≥ 10 cells/mm3 for infants 29 to 60 days of age

d

Bacteremia and/or bacterial meningitis

e

Infants may have had more than one type of SBI

CSF: cerebrospinal fluid; EV: Enterovirus; PCR: polymerase chain reaction; WBC: white blood cell; SBI: serious bacterial infection; UTI: urinary tract infection